Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Growth Metrics

Marimed (MRMD) Long-Term Deferred Tax (2019 - 2020)

Marimed has reported Long-Term Deferred Tax over the past 2 years, most recently at $57.9 million for Q4 2020.

Quarterly Long-Term Deferred Tax fell 16.02% to $57.9 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $57.9 million through Dec 2020, down 16.02% year-over-year, with the annual reading at $57.9 million for FY2020, 16.02% down from the prior year.
Long-Term Deferred Tax was $57.9 million for Q4 2020 at Marimed, down from $68.9 million in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $68.9 million in Q4 2019 and troughed at $57.9 million in Q4 2020.